Participating Faculty: NSAIDs: Optimizing Pain Management Through Risk Reduction

This supplement to The American Journal of Managed Care provides a clinical overview of pain management and the value of treatment with nonsteroidal anti-inflammatory drugs (NSAIDs). The discussion includes evidence that helps quantify the clinical and economic impact of serious adverse events associated with NSAIDs. Also discussed is the role of dose reduction in mitigating these risks and the potential benefits associated with new lower-dose NSAID formulations.This supplement was supported by Iroko Pharmaceuticals, LLC.

Michael Fine, MD

Medical Director

Health Net

Laguna Beach, California

Michele L. Matthews, PharmD, CPE, BCACP

Associate Professor

Department of Pharmacy Practice

School of Pharmacy, Boston

MCPHS University

Boston, Massachusetts

Advanced Pharmacist Practitioner

Brigham and Women’s Hospital

Pain Management Center

Chestnut Hill, Massachusetts

Srinivas Nalamachu, MD

Medical Director

International Clinical Research Institute

Overland Park, Kansas

Faculty Disclosures

Srinivas Nalamachu, MD

Consultant/advisory board/honoraria/lecture fees: Iroko Pharmaceuticals, LLC

Michael Fine, MD, and Michele L. Matthews, PharmD, CPE, BCACP, have no relevant financial relationships with commercial interests to disclose.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Download PDF: Participating Faculty: NSAIDs: Optimizing Pain Management Through Risk Reduction